Results 61 to 70 of about 4,991,463 (296)

Epidemiological and comorbidity burden in transfusion-dependent patients with thalassemia and sickle cell disease in Greece

open access: yesAnnals of Hematology
TDT and SCD are hereditary hemoglobinopathies that require lifelong red blood cell transfusions. Modern treatment has increased survival, exposing patients to transfusion-related problems such iron excess.
Sophia Delicou   +6 more
doaj   +1 more source

Model‐Informed Evaluation of Hydroxyurea Exposure During Lactation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Hydroxyurea is a cornerstone therapy for sickle cell anemia; however, evidence guiding its use during lactation remains limited. This study aimed to develop a population pharmacokinetic (PK) model to characterize hydroxyurea disposition in maternal plasma and breast milk, and to quantify infant exposure under clinically relevant breastfeeding scenarios.
Anhar Hosawi   +5 more
wiley   +1 more source

Association between maternal pre‐pregnancy body mass index and maternal and neonatal outcomes in Saudi Arabia: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective The body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of the mother before pregnancy and the growth of weight during pregnancy are both important perinatal health determinants. The aim of the present study was to examine the association between the maternal BMI and obstetric and ...
Randa Elsayed   +7 more
wiley   +1 more source

Sickle Cell Disease (SCD) in California, 2016 [PDF]

open access: yes
We found 4,689 people with SCD were living in California in 2016.CS 310397-C2016-snapshot-sickle-cell-ca-508.pdf?deliveryName=USCDC_1391 ...

core  

Relationships Between Markers of Iron Status and Hematological Parameters in Patients With Sickle Cell Disease

open access: yesAdvances in Hematology
Based on the relationship between the intracellular concentration of sickle hemoglobin S (HbS) and the delay that occurs prior to the onset of sickling following deoxygenation, targeting the intracellular HbS concentration is a recognized therapeutic ...
Nermi L. Parrow   +4 more
doaj   +1 more source

Fetal growth trajectories and neonatal outcomes: A French population‐based study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study assesses whether fetal growth trajectories are associated with neonatal outcomes. Methods The study population included 8537 singleton liveborn infants from the 2021 French National Perinatal Survey. Fetal growth trajectories were assessed between second and third trimester routine ultrasounds and between the third ...
Pierre Gibert   +22 more
wiley   +1 more source

Antiviral response and HIV-1 inhibition in sickle cell disease

open access: yesiScience
Summary: Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion, and ischemia. HIV-1 infection was previously shown to be suppressed in SCD PBMCs.
Namita Kumari   +10 more
doaj   +1 more source

Anti‐Erythrocyte Antibody Formation in Individuals With and Without Known Sensitisation Pathways Reflecting Indications for Extended Immunohaematology Screening

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
– The yearly incidence of anti‐red blood cell antibodies stratified by participant groups and temporal evolution. – Overall significance p = 3.756 × 10−29. ABSTRACT Background Blood transfusion therapies are of vital importance for many patient groups.
Milanka Milosavić   +3 more
wiley   +1 more source

Get screened to know your sickle cell status [PDF]

open access: yes
To find out whether you or your loved one has sickle cell disease (SCD) or sickle cell trait (SCT), blood tests must be done to screen for these conditions.

core  

Home - About - Disclaimer - Privacy